tiprankstipranks
pc:cirru

Cirrus Therapeutics

Cirrus Therapeutics is a privately held biotech company specializing in ocular immunology. The company is pioneering innovative cell and gene therapies to treat age-related macular degeneration (AMD) and other chronic blinding diseases. Their lead program features a novel adeno-associated virus (AAV) gene therapy aimed at restoring IRAK-M, a crucial immune regulator in retinal cells, to combat dry AMD and preserve vision. Cirrus Therapeutics is committed to advancing ocular health and improving the quality of life for patients as they age.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$11M
Total Amount Raised$11M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$11M
Latest Funding Amount$11M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 08, 2025
Seed Round
$11.00M

Investors

Investor Name
Funding Round
Seed Round
Seed Round

Related News and Analysis